Report Overview
The surge in prevalence of sexually transmitted infections (STIs), including HSV infections, is driving demand for STIs testing and treatment. In addition, increase in awareness of the importance of sexual health is leading to increased demand for HSV treatments, as patients seek to manage their symptoms and reduce the risk of transmission. This has reduced the stigma associated with HSV infections and has led to increase in demand for treatments that helps to manage symptoms and reduce the risk of transmission. Furthermore, increase in healthcare expenditure in developing countries has increased access to healthcare services, including HSV treatment. This has increased the access to healthcare and surged the demand for herpes simplex virus treatment.
The global Herpes Simplex Virus Treatment market size is projected to grow from US$ 1779 million in 2024 to US$ 2128 million in 2030; it is expected to grow at a CAGR of 3.0% from 2024 to 2030.
Analytic Insights Hub ' newest research report, the “Herpes Simplex Virus Treatment Industry Forecast” looks at past sales and reviews total world Herpes Simplex Virus Treatment sales in 2023, providing a comprehensive analysis by region and market sector of projected Herpes Simplex Virus Treatment sales for 2024 through 2030. With Herpes Simplex Virus Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Herpes Simplex Virus Treatment industry.
This Insight Report provides a comprehensive analysis of the global Herpes Simplex Virus Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Herpes Simplex Virus Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Herpes Simplex Virus Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Herpes Simplex Virus Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Herpes Simplex Virus Treatment.
The surge in prevalence of sexually transmitted infections (STIs), including HSV infections, is driving demand for STIs testing and treatment. In addition, increase in awareness of the importance of sexual health is leading to increased demand for HSV treatments, as patients seek to manage their symptoms and reduce the risk of transmission. This has reduced the stigma associated with HSV infections and has led to increase in demand for treatments that helps to manage symptoms and reduce the risk of transmission. Furthermore, increase in healthcare expenditure in developing countries has increased access to healthcare services, including HSV treatment. This has increased the access to healthcare and surged the demand for herpes simplex virus treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Herpes Simplex Virus Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Acyclovir
Valacyclovir
Famciclovir
Segmentation by Application:
Drug Store and Retail Pharmacies
Online Providers
Hospital Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Viatris Inc
Abbott Laboratories
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline Plc
Pfizer Inc
Novartis AG
Fresenius SE and Co. KGaA
Amneal Pharmaceuticals LLC
Glenmark Pharmaceuticals Limited
Emcure Pharmaceuticals Limited
Key Questions Addressed in this Report
What is the 10-year outlook for the global Herpes Simplex Virus Treatment market?
What factors are driving Herpes Simplex Virus Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Herpes Simplex Virus Treatment market opportunities vary by end market size?
How does Herpes Simplex Virus Treatment break out by Type, by Application?
Table Of Contents
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2017-2029)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Herpes Simplex Virus Treatment Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Herpes Simplex Virus Treatment Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Herpes Simplex Virus Treatment Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by region)
5 Global Herpes Simplex Virus Treatment Market-Segmentation by Type
5.1 Type 1
5.2 Type 2
5.3 Type 3
6 Global Herpes Simplex Virus Treatment Market-Segmentation by Application
6.1 Application 1
6.2 Application 2
6.3 Application 3
7 Global Herpes Simplex Virus Treatment Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence A Company Profiles
8.1 Company 1
8.1.1 Company 1 Profile
8.1.2 Company 1 Sales, Growth Rate and Global Market Share from 2017-2023
8.1.3 Company 1 Product/Solution Launches and Enhancements Analysis
8.1.4 Company 1 Business Overview/Recent Development/Acquisitions
8.2 Company 2
8.2.1 Company 2 Profile
8.2.2 Company 2 Sales, Growth Rate and Global Market Share from 2017-2023
8.2.3 Company 2 Product/Solution Launches and Enhancements Analysis
8.2.4 Company 2 Business Overview/Recent Development/Acquisitions
8.3 Company 3
8.3.1 Company 3 Profile
8.3.2 Company 3 Sales, Growth Rate and Global Market Share from 2017-2023
8.3.3 Company 3 Product/Solution Launches and Enhancements Analysis
8.3.4 Company 3 Business Overview/Recent Development/Acquisitions
8.4 Company 4
8.4.1 Company 4 Profile
8.4.2 Company 4 Sales, Growth Rate and Global Market Share from 2017-2023
8.4.3 Company 4 Product/Solution Launches and Enhancements Analysis
8.4.4 Company 4 Business Overview/Recent Development/Acquisitions
8.5 Company 5
8.5.1 Company 5 Profile
8.5.2 Company 5 Sales, Growth Rate and Global Market Share from 2017-2023
8.5.3 Company 5 Product/Solution Launches and Enhancements Analysis
8.5.4 Company 5 Business Overview/Recent Development/Acquisitions
8.6 Company 6
8.6.1 Company 6 Profile
8.6.2 Company 6 Sales, Growth Rate and Global Market Share from 2017-2023
8.6.3 Company 6 Product/Solution Launches and Enhancements Analysis
8.6.4 Company 6 Business Overview/Recent Development/Acquisitions
8.7 Company 7
8.7.1 Company 7 Profile
8.7.2 Company 7 Sales, Growth Rate and Global Market Share from 2017-2023
8.7.3 Company 7 Product/Solution Launches and Enhancements Analysis
8.7.4 Company 7 Business Overview/Recent Development/Acquisitions
8.8 Company 8
8.8.1 Company 8 Profile
8.8.2 Company 8 Sales, Growth Rate and Global Market Share from 2017-2023
8.8.3 Company 8 Product/Solution Launches and Enhancements Analysis
8.8.4 Company 8 Business Overview/Recent Development/Acquisitions
8.9 Company 9
8.9.1 Company 9 Profile
8.9.2 Company 9 Sales, Growth Rate and Global Market Share from 2017-2023
8.9.3 Company 9 Product/Solution Launches and Enhancements Analysis
8.9.4 Company 9 Business Overview/Recent Development/Acquisitions
8.10 Company 10
8.10.1 Company 10 Profile
8.10.2 Company 10 Sales, Growth Rate and Global Market Share from 2017-2023
8.10.3 Company 10 Product/Solution Launches and Enhancements Analysis
8.10.4 Company 10 Business Overview/Recent Development/Acquisitions
8.11 Company 11
8.11.1 Company 11 Profile
8.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2017-2023
8.11.3 Company 11 Product/Solution Launches and Enhancements Analysis
8.11.4 Company 11 Business Overview/Recent Development/Acquisitions
8.12 Company 12
8.12.1 Company 12 Profile
8.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2017-2023
8.12.3 Company 12 Product/Solution Launches and Enhancements Analysis
8.12.4 Company 12 Business Overview/Recent Development/Acquisitions
8.13 Company 13
8.13.1 Company 13 Profile
8.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2017-2023
8.13.3 Company 13 Product/Solution Launches and Enhancements Analysis
8.13.4 Company 13 Business Overview/Recent Development/Acquisitions
8.14 Company 14
8.14.1 Company 14 Profile
8.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2017-2023
8.14.3 Company 14 Product/Solution Launches and Enhancements Analysis
8.14.4 Company 14 Business Overview/Recent Development/Acquisitions
8.15 Company 15
8.15.1 Company 15 Profile
8.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2017-2023
8.15.3 Company 15 Product/Solution Launches and Enhancements Analysis
8.15.4 Company 15 Business Overview/Recent Development/Acquisitions
9 Global Herpes Simplex Virus Treatment Market-Segmentation by Geography
10 North America
10.1 North America Herpes Simplex Virus Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
10.2 North America Herpes Simplex Virus Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
10.3 North America Herpes Simplex Virus Treatment Production Analysis from 2017-2023
10.4 North America Herpes Simplex Virus Treatment Consumption Analysis from 2017-2023
10.5 North America Herpes Simplex Virus Treatment Import and Export from 2017-2023
10.6 North America Herpes Simplex Virus Treatment Value, Production and Market Share by Type (2017-2023)
10.7 North America Herpes Simplex Virus Treatment Consumption, Value and Market Share by Application (2017-2023)
10.8 North America Herpes Simplex Virus Treatment by Country (United States, Canada)
10.8.1 North America Herpes Simplex Virus Treatment Sales by Country (2017-2023)
10.8.2 North America Herpes Simplex Virus Treatment Consumption Value by Country (2017-2023)
10.9 North America Herpes Simplex Virus Treatment Market PEST Analysis
11 Europe
11.1 Europe Herpes Simplex Virus Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
11.2 Europe Herpes Simplex Virus Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
11.3 Europe Herpes Simplex Virus Treatment Production Analysis from 2017-2023
11.4 Europe Herpes Simplex Virus Treatment Consumption Analysis from 2017-2023
11.5 Europe Herpes Simplex Virus Treatment Import and Export from 2017-2023
11.6 Europe Herpes Simplex Virus Treatment Value, Production and Market Share by Type (2017-2023)
11.7 Europe Herpes Simplex Virus Treatment Consumption, Value and Market Share by Application (2017-2023)
11.8 Europe Herpes Simplex Virus Treatment by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Herpes Simplex Virus Treatment Sales by Country (2017-2023)
11.8.2 Europe Herpes Simplex Virus Treatment Consumption Value by Country (2017-2023)
11.9 Europe Herpes Simplex Virus Treatment Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Herpes Simplex Virus Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
12.2 Asia-Pacific Herpes Simplex Virus Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
12.3 Asia-Pacific Herpes Simplex Virus Treatment Production Analysis from 2017-2023
12.4 Asia-Pacific Herpes Simplex Virus Treatment Consumption Analysis from 2017-2023
12.5 Asia-Pacific Herpes Simplex Virus Treatment Import and Export from 2017-2023
12.6 Asia-Pacific Herpes Simplex Virus Treatment Value, Production and Market Share by Type (2017-2023)
12.7 Asia-Pacific Herpes Simplex Virus Treatment Consumption, Value and Market Share by Application (2017-2023)
12.8 Asia-Pacific Herpes Simplex Virus Treatment by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Herpes Simplex Virus Treatment Sales by Country (2017-2023)
12.8.2 Asia-Pacific Herpes Simplex Virus Treatment Consumption Value by Country (2017-2023)
12.9 Asia-Pacific Herpes Simplex Virus Treatment Market PEST Analysis
13 Latin America
13.1 Latin America Herpes Simplex Virus Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
13.2 Latin America Herpes Simplex Virus Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
13.3 Latin America Herpes Simplex Virus Treatment Production Analysis from 2017-2023
13.4 Latin America Herpes Simplex Virus Treatment Consumption Analysis from 2017-2023
13.5 Latin America Herpes Simplex Virus Treatment Import and Export from 2017-2023
13.6 Latin America Herpes Simplex Virus Treatment Value, Production and Market Share by Type (2017-2023)
13.7 Latin America Herpes Simplex Virus Treatment Consumption, Value and Market Share by Application (2017-2023)
13.8 Latin America Herpes Simplex Virus Treatment by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Herpes Simplex Virus Treatment Sales by Country (2017-2023)
13.8.2 Latin America Herpes Simplex Virus Treatment Consumption Value by Country (2017-2023)
13.9 Latin America Herpes Simplex Virus Treatment Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Herpes Simplex Virus Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
14.2 Middle East & Africa Herpes Simplex Virus Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
14.3 Middle East & Africa Herpes Simplex Virus Treatment Production Analysis from 2017-2023
14.4 Middle East & Africa Herpes Simplex Virus Treatment Consumption Analysis from 2017-2023
14.5 Middle East & Africa Herpes Simplex Virus Treatment Import and Export from 2017-2023
14.6 Middle East & Africa Herpes Simplex Virus Treatment Value, Production and Market Share by Type (2017-2023)
14.7 Middle East & Africa Herpes Simplex Virus Treatment Consumption, Value and Market Share by Application (2017-2023)
14.8 Middle East & Africa Herpes Simplex Virus Treatment by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Herpes Simplex Virus Treatment Sales by Country (2017-2023)
14.8.2 Middle East & Africa Herpes Simplex Virus Treatment Consumption Value by Country (2017-2023)
14.9 Middle East & Africa Herpes Simplex Virus Treatment Market PEST Analysis
15 Future Forecast of the Global Herpes Simplex Virus Treatment Market from 2023-2029
15.1 Future Forecast of the Global Herpes Simplex Virus Treatment Market from 2023-2029 Segment by Region
15.2 Global Herpes Simplex Virus Treatment Production and Growth Rate Forecast by Type (2023-2029)
15.3 Global Herpes Simplex Virus Treatment Consumption and Growth Rate Forecast by Application (2023-2029)
16 Appendix
16.1 Methodology
16.2 Research Data Source